Efficacy and safety of repeated use of lusutrombopag prior to radiofrequency ablation in patients with recurrent hepatocellular carcinoma and thrombocytopenia.

MLA

Ishikawa, Toru, et al. “Efficacy and Safety of Repeated Use of Lusutrombopag Prior to Radiofrequency Ablation in Patients with Recurrent Hepatocellular Carcinoma and Thrombocytopenia.” Hepatology Research : The Official Journal of the Japan Society of Hepatology, vol. 49, no. 5, May 2019, pp. 590–93. EBSCOhost, https://doi.org/10.1111/hepr.13305.

APA

Ishikawa, T., Okoshi, M., Tomiyoshi, K., Kojima, Y., Horigome, R., Imai, M., Nozawa, Y., Iwanaga, A., Sano, T., Honma, T., & Yoshida, T. (2019). Efficacy and safety of repeated use of lusutrombopag prior to radiofrequency ablation in patients with recurrent hepatocellular carcinoma and thrombocytopenia. Hepatology Research : The Official Journal of the Japan Society of Hepatology, 49(5), 590–593. https://doi.org/10.1111/hepr.13305

Chicago

Ishikawa, Toru, Marina Okoshi, Kei Tomiyoshi, Yuichi Kojima, Ryoko Horigome, Michitaka Imai, Yujiro Nozawa, et al. 2019. “Efficacy and Safety of Repeated Use of Lusutrombopag Prior to Radiofrequency Ablation in Patients with Recurrent Hepatocellular Carcinoma and Thrombocytopenia.” Hepatology Research : The Official Journal of the Japan Society of Hepatology 49 (5): 590–93. doi:10.1111/hepr.13305.